Case number 1:18-cv-00150
H. Lundbeck A/S et al v. Zydus Pharmaceuticals (USA) Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 29, 2021 | 23 | Final Judgment (9) |
| Oct 29, 2021 | 23 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks (Attachments: # (1) Final Judgment)(ntl) |
| Oct 29, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (See D.I. 1090 in lead case no. 18-88-LPS) Associated Cases: 1:18-cv-00113-LPS et al. (ntl) |
| Jan 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 1/16/2019. Associated Cases: 1:18-cv-00088-LPS et al.(dlb) |
| Jan 10, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00088-LPS et al.(cak) |
| Jul 9, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00088-LPS. (ntl) |
| Jul 3, 2018 | 22 | Letter to The Honorable Leonard P. Stark (1) |
| Jul 3, 2018 | 22 | Main Document (22) Docket Text: PROPOSED ORDER -- Scheduling Order -- by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Letter to The Honorable Leonard P. Stark)(Blumenfeld, Jack) |
| Jun 19, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Case Management Conference held on 6/19/2018. (Court Reporter: Hawkins Reporting) Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Jun 12, 2018 | 21 | Cover Letter (1) |
| Jun 12, 2018 | 21 | Main Document (23) Docket Text: PROPOSED ORDER Scheduling Order by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Cover Letter)(Blumenfeld, Jack) |
| Jun 8, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (21 in 1:18-cv-00177-LPS, 21 in 1:18-cv-00089-LPS, 23 in 1:18-cv-00114-LPS, 17 in 1:18-cv-00147-LPS, 41 in 1:18-cv-00175-LPS, 15 in 1:18-cv-00092-LPS, 12 in 1:18-cv-00672-LPS, 13 in 1:18-cv-00671-LPS, 28 in 1:18-cv-00088-LPS, 23 in 1:18-cv-00113-LPS, 11 in 1:18-cv-00753-LPS, 9 in 1:18-cv-00777-LPS, 23 in 1:18-cv-00148-LPS, 20 in 1:18-cv-00150-LPS, 20 in 1:18-cv-00176-LPS, 19 in 1:18-cv-00091-LPS, 17 in 1:18-cv-00090-LPS, 16 in 1:18-cv-00149-LPS) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 filed by Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 6/7/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Jun 6, 2018 | 20 | Stipulation to EXTEND Time (14) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Blumenfeld, Jack) |
| May 23, 2018 | 19 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Megan C. Haney on behalf of Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Haney, Megan) |
| May 23, 2018 | N/A | Order Setting Scheduling Conference (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Court will hold a Case Management Conference in courtroom 6B on June 19, 2018 at 9:00 a.m. In preparation for the CMC, counsel shall meet and confer and address the items listed in the "Checklist," and submit a proposed scheduling order no later than June 6, 2018. ORDERED by Judge Leonard P. Stark on 5/23/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Apr 26, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:18-cv-00147-LPS, 19 in 1:18-cv-00148-LPS, 12 in 1:18-cv-00177-LPS, 14 in 1:18-cv-00149-LPS, 14 in 1:18-cv-00090-LPS, 17 in 1:18-cv-00150-LPS, 18 in 1:18-cv-00176-LPS, 11 in 1:18-cv-00092-LPS, 16 in 1:18-cv-00114-LPS, 19 in 1:18-cv-00113-LPS, 18 in 1:18-cv-00089-LPS, 23 in 1:18-cv-00088-LPS, 23 in 1:18-cv-00175-LPS, 16 in 1:18-cv-00091-LPS) MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, and Brianne Bharkhda of Covington & Burling LLP filed by Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 4/26/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Apr 25, 2018 | 17 | Motion for Leave to Appear Pro Hac Vice (19) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, and Brianne Bharkhda of Covington & Burling LLP - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Dellinger, Megan) |
| Apr 9, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael J. Gaertner for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Apr 6, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher J. Cassella,Timothy F. Peterson,Carolyn A. Blessing,David B. Abramowitz for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Apr 4, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn Blessing, Timothy F. Peterson and Christopher J. Cassella filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd. Signed by Judge Leonard P. Stark on 4/4/18. (ntl) |
| Apr 3, 2018 | 16 | Certification of Timothy F. Peterson (1) |
| Apr 3, 2018 | 16 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn Blessing, Timothy F. Peterson and Christopher J. Cassella - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: # (1) Certification of Michael J. Gaertner, # (2) Certification of David B. Abramowitz, # (3) Certification of Carolyn Blessing, # (4) Certification of Timothy F. Peterson, # (5) Certification of Christopher J. Cassella)(Bilson, David) |
| Apr 3, 2018 | 16 | Certification of Michael J. Gaertner (1) |
| Apr 3, 2018 | 16 | Certification of David B. Abramowitz (1) |
| Apr 3, 2018 | 16 | Certification of Carolyn Blessing (1) |
| Apr 3, 2018 | 16 | Certification of Christopher J. Cassella (1) |
| Apr 2, 2018 | 13 | Answer to Amended Complaint (29) Docket Text: ANSWER to Amended Complaint, re: [11] Amended Complaint, Affirmative Defenses by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Phillips, John) |
| Apr 2, 2018 | 14 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cadila Healthcare Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Phillips, John) |
| Apr 2, 2018 | 15 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cadila Healthcare Ltd.. (Phillips, John) |
| Mar 19, 2018 | 11 | Amended Complaint* (1) |
| Mar 19, 2018 | 12 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,861,630 B1; . (Noreika, Maryellen) |
| Mar 19, 2018 | 11 | Exhibit A - F (220) |
| Mar 19, 2018 | 11 | Main Document (27) Docket Text: First AMENDED COMPLAINT against Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.- filed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd.. (Attachments: # (1) Exhibit A - F)(Noreika, Maryellen) |
| Feb 1, 2018 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd.: For Cadila Healthcare Ltd. waiver sent on 1/31/2018, answer due 4/2/2018. (Noreika, Maryellen) |
| Feb 1, 2018 | 9 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Cadila Healthcare Ltd (d/b/a Zydus Cadila) on 1/31/2018 by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. Waiver of Service due by 3/5/2018. (Noreika, Maryellen) |
| Feb 1, 2018 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd.: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 1/31/2018, answer due 4/2/2018. (Noreika, Maryellen) |
| Feb 1, 2018 | 7 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Zydus Pharmaceuticals (USA) Inc. on 1/31/2018 by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. Waiver of Service due by 3/5/2018. (Noreika, Maryellen) |
| Jan 31, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:18-cv-00147-LPS, 1:18-cv-00148-LPS, 1:18-cv-00149-LPS, 1:18-cv-00150-LPS (rjb) |
| Jan 26, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cadila Healthcare Ltd. on 1/26/2018; Zydus Pharmaceuticals (USA) Inc. on 1/26/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmfn) |
| Jan 25, 2018 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Ltd., Corporate Parent Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc.; Corporate Parent Takeda Pharmaceuticals U.S.A., Inc. for Takeda Pharmaceuticals America, Inc.; Corporate Parent Takeda Pharmaceutical Company Ltd., Corporate Parent Takeda Pharma A/S, Corporate Parent Takeda Europe Holdings B.V., Corporate Parent Takeda A/S for Takeda Pharmaceuticals International AG filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc. (nmfn) |
| Jan 25, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (nmfn) |
| Jan 25, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,144,884 B2; 8,476,279 B2; 8,722,684 B2; 8,969,355 B2; 9,227,946 B2. (nmfn) |
| Jan 25, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/14/2017. Date of Expiration of '884 and '279 Patents: 10/2/2022. Date of Expiration of '355 and '946 Patents: 6/15/2027. Date of expiration of '684 Patent: 6/30/2031. Thirty Month Stay Deadline: 3/30/2021. (nmfn) |
| Jan 25, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
| Jan 25, 2018 | 1 | Civil Cover Sheet (2) |
| Jan 25, 2018 | 1 | Exhibits A-E (173) |
| Jan 25, 2018 | 1 | Complaint* (1) |
| Jan 25, 2018 | 1 | Main Document (24) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2309331.) - filed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd. (Attachments: # (1) Exhibits A-E, # (2) Civil Cover Sheet)(nmfn) |
